Emyria Ltd
ASX:EMD

Watchlist Manager
Emyria Ltd Logo
Emyria Ltd
ASX:EMD
Watchlist
Price: 0.053 AUD 1.92%
Market Cap: 42.6m AUD

Net Margin
Emyria Ltd

-225.3%
Current
-372%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-225.3%
=
Net Income
-3.1m
/
Revenue
1.4m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
AU
Emyria Ltd
ASX:EMD
42.6m AUD
-225%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
496.3B USD
27%
CH
Roche Holding AG
SIX:ROG
262.9B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
212.8B GBP
16%
CH
Novartis AG
SIX:NOVN
212.1B CHF
26%
US
Merck & Co Inc
NYSE:MRK
260.5B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
33%
IE
Endo International PLC
LSE:0Y5F
209B USD
-126%
US
Pfizer Inc
NYSE:PFE
143B USD
16%
No Stocks Found

Emyria Ltd
Glance View

Market Cap
42.6m AUD
Industry
Pharmaceuticals

Emyria Ltd. is a healthcare technology and services company. The firm provides care for its patients through its clinics gathering real-world-evidence (RWE) insights in relation to therapies, such as cannabinoid-based medicines and drug development. Its evidence-based drug development program (EMD-003) is focused on mental health and EMD-004 is focused on irritable bowel syndrome (IBS). The Company’s subsidiaries include Emyria Clinical Network Pty Ltd and Openly Care Inc.

EMD Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-225.3%
=
Net Income
-3.1m
/
Revenue
1.4m
What is the Net Margin of Emyria Ltd?

Based on Emyria Ltd's most recent financial statements, the company has Net Margin of -225.3%.

Back to Top